Keystone-SDA
Eye care products specialist Alcon made further progress in the third quarter of this year. The results, however, are a little lower than expected. For the year as a whole, the group is moderating its ambitions somewhat.
This content was published on
November 12, 2024 – 6.59pm
(Keystone-ATS) Quarterly turnover increased by 6% to $2.43 billion, Alcon said Tuesday evening, exceptionally after the closing of the Swiss stock exchange, which led to a suspension of trading on the American Stock Exchange.
Adjusted for the effects of exchange rates, turnover remained virtually unchanged, also gaining around 6%. In the second quarter, the increase in local currencies was of the same order.
In terms of profits, Alcon reports improvements. The basic Ebitda margin stood at 20.6% compared to 19.5% in the third quarter of 2023. Net income stood at $263 (204) million and net earnings per share at 0.81 (0. 66) dollar.
The numbers are largely a bit lower than AWP consensus analysts’ expectations.
Quoted in the press release, boss David J. Endicott notes that the third quarter reflects the wide geographic distribution and the excellence of the teams’ work. For 2025 and beyond, the focus remains on launching a wave of innovative products that will ensure future growth.
For 2024 as a whole, Alcon now expects revenue of $9.8 to $9.9 billion, up from $9.9 to $10.1 billion previously. Core Ebitda margin is expected to reach 20.5-21.0% (previously: 20.5-21.5%) and core earnings per share $3.00-3.05 (previously $3.00-3.05). 10 dollars).
Business
